Wife is on other ‘bio-similar’ or ‘bio-identical’ medications so I do understand. That said, the old bio-similars that are now generic and relatively inexpensive do work well enough for now that we are letting others pay for the R&D of the next generation. Somebody has to pay those costs, which are real and not insignificant. It is unfortunate for those who have no choice, but the alternative is horrible abuse.
” do work well enough for now ...”
Sorry to hear about the wife. As a “seasoned” diabetic, I can understand the difficulties.
But the truly unfortunate part of generics is that they are not as effective as the main drugs as they are watered down to cut costs and availability. There is a market for them however as these are the drugs advertised as being sold to other countries at cut costs, in many cases even more watered down, so it appears to be inexpensive but really is cheap.
And how much collateral damage to heart and kidneys cannot be measured with their limited capacity and the inconsistent with the severity of the illness. So, they may be partially effective at the moment, for numbers, but the wolf is at the door for other reasons. Hope she lives to 100.
wy69